COMPANY PROFILE

KLISBio

Explore full profile

Silk innovation for life sciences

Bresso, ItalyFounded 2014Biotech & Life Sciences

Valuation $25–50M Last recorded · 2021

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About KLISBio

We are challenging the status quo in regenerative medicine by leveraging silk as a powerful and biocompatible scaffold material. We are targeting different clinical indications in the orthopaedic and vascular markets via several technology platforms.

Source: Dealroom company data

At a glance

Founded: 2014
Headquarters: Bresso, Italy
Sector: Biotech & Life Sciences

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

ECEuropean Commission
ECEuropean Innovation Council

Series A4 investors entered at this stage

PSPrincipia SGR
XYXYence
CCCDP Venture Capital
EFEIC Fund

Talent

Book a demo to see the people

Team profiled 7 named & role-tagged

Founders /100 quality score

Key operators 5 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

2 countries with
team presence

🇮🇹 Italy94.7%

🇺🇸 United States5.3%

2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about KLISBio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See KLISBio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles